These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9446081)

  • 21. Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients.
    Sun JY; Dagis A; Gaidulis L; Miller MM; Rodriguez R; Parker P; Nademanee A; Falk P; Rosenthal J; Forman SJ; Senitzer D
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):197-205. PubMed ID: 17241925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease.
    Merrill J; Jondal M; Seeley J; Ullberg M; Sidén A
    Clin Exp Immunol; 1982 Feb; 47(2):419-30. PubMed ID: 6176377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?
    Lünemann JD; Münz C
    Brain; 2008 Jul; 131(Pt 7):1681-3. PubMed ID: 18586760
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevated direct and IgM enhanced ADCC activity in multiple sclerosis patients.
    Merrill JE; Wåhlin B; Sidén A; Perlmann P
    J Immunol; 1982 Apr; 128(4):1728-35. PubMed ID: 7037955
    [No Abstract]   [Full Text] [Related]  

  • 25. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
    Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
    J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Circulating serum interferon and its effect on human natural killer cell activity].
    Cheknev SB; Ashmanova IaG; Pritsker AD; Latysheva OL
    Biull Eksp Biol Med; 1994 Dec; 118(12):619-22. PubMed ID: 7535580
    [No Abstract]   [Full Text] [Related]  

  • 28. [Change in the activity of natural killer cells in normal subjects and in virus diseases on exposure to interferon in vitro].
    Petrov RV; Saidov MZ; Koval'chuk LV; Sorokin AM; Kaganov BS
    Biull Eksp Biol Med; 1984 Apr; 97(4):438-40. PubMed ID: 6722306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cimetidine reduces impairment of cellular immunity after transcatheter arterial embolization in patients with hepatocellular carcinoma.
    Nishiguchi S; Tamori A; Shiomi S; Enomoto M; Tatsumi N; Koh N; Habu D; Sakaguchi H; Takeda T; Seki S; Nakamura K; Kubo S; Kinoshita H
    Hepatogastroenterology; 2003; 50(50):460-2. PubMed ID: 12749247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
    Katsarou Z; Bostantjopoulou S; Hatzizisi O; Giza E; Soler-Cardona A; Kyriazis G
    Rev Neurol; 2007 Dec 16-31; 45(12):725-8. PubMed ID: 18075986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
    Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
    Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histocompatibility antigens in multiple sclerosis patients].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM; Kut'ina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):7-10. PubMed ID: 7234266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.
    Rudnick CC; Franceschi DS; Marangon AV; Guelsin GA; Sell AM; Visentainer JE
    Hum Immunol; 2008 Dec; 69(12):872-6. PubMed ID: 18848853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA related genetic control of natural killer activity and aflatoxin B1 suppression of lymphocytic blastogenesis.
    Wang CY; Yu XS; Hong JX; Lin TZ; Yang YQ
    Chin Med J (Engl); 1987 Jan; 100(1):29-33. PubMed ID: 3109821
    [No Abstract]   [Full Text] [Related]  

  • 37. [In vitro and clinical effect of pentoxifylline on natural killer cell activity].
    Nagy Z; Sipka R; Ocsovszki I; Balogh A; Mándi Y
    Orv Hetil; 1998 Oct; 139(41):2441-5. PubMed ID: 9805458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cells in human peripheral blood and primary cutaneous natural killer cell lymphomas may express cutaneous lymphocyte antigen.
    Chang SE; Kim MJ; Lee WS; Kang YK; Moon KC; Koh JK; Choi JH
    Acta Derm Venereol; 2003; 83(3):162-6. PubMed ID: 12816147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of HLA-DR2 on perforin-positive cells in pulmonary tuberculosis.
    Rajeswari DN; Selvaraj P; Raghavan S; Jawahar MS; Narayanan PR
    Int J Immunogenet; 2007 Oct; 34(5):379-84. PubMed ID: 17845310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia.
    Aizen E; Kagan G; Assy B; Iobel R; Bershadsky Y; Gilhar A
    Isr Med Assoc J; 2005 Feb; 7(2):78-81. PubMed ID: 15729955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.